Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

Clinical trial NCT00440011 · COMPLETED

Trial details

NCT number: NCT00440011
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2006-08-01
Primary completion: 2007-10-01
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.